SUPERIOR EFFECTS OF STRONTIUM RANELATE COMPARED TO ALENDRONATE ON BONE MASS AND STRENGTH PARAMETERS AT THE TIBIA IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Felsenberg, Dieter [1 ]
Brandi, Maria Luisa [7 ]
Sergi, Giuseppe [8 ]
Bergstrom, Ingrid [9 ]
Beller, Gisela [1 ]
Fiore, Carmelo [2 ]
Lyritis, George [3 ]
Kindmark, Andreas [4 ]
Boerst, Hendrikje [1 ]
Bock, Oliver [1 ]
Hartard, Manfred [5 ]
Runge, Martin [6 ]
机构：
[1] Charite Campus Benjamin Franklin, Berlin, Germany
[2] Clin Med Osp Vittorio Emanuele, Catania, Italy
[3] KAT Hosp, Kifisia, Greece
[4] Univ Uppsala Hosp, Uppsala, Sweden
[5] Cent Diagnost & Gesundheit, Munich, Germany
[6] Aerpah Klin, Esslingen, Germany
[7] Policlin Careggi, Florence, Italy
[8] Clin Geriatr, Padua, Italy
[9] Karolinska Univ Sjukhuset Huddinge, Stockholm, Sweden
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [41] The Effects of Strontium Ranelate in Asian Women with Postmenopausal Osteoporosis (vol 83, pg 308, 2008)
    Hwang, J. S.
    Chen, J. F.
    Yang, T. S.
    Wu, D. J.
    Tsai, K. S.
    Ho, C.
    Wu, C. H.
    Su, S. L.
    Wang, C. J.
    Tu, S. T.
    CALCIFIED TISSUE INTERNATIONAL, 2009, 84 (04) : 334 - 334
  • [42] Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosisResults of a 2-year study
    R. Rizzoli
    R. D. Chapurlat
    J.-M. Laroche
    M. A. Krieg
    T. Thomas
    I. Frieling
    S. Boutroy
    A. Laib
    O. Bock
    D. Felsenberg
    Osteoporosis International, 2012, 23 : 305 - 315
  • [43] Possibility of bone metabolism modulator (strontium ranelate) usage for the treatment of women with postmenopausal osteoporosis and arterial hypertension
    Hozjainova, N. J.
    Tsareva, V. M.
    Brook, T. V.
    Bezaltynnyh, M. S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (02) : 18 - 21
  • [44] BENEFICIAL EFFECTS OF STRONTIUM RANELATE COMPARED TO ALENDRONATE ON BONE BIOMECHANICAL PROPERTIES ASSESSED BY FINITE ELEMENT ANALYSIS
    Boutroy, Stephanie
    Rizzoli, Rene
    Chapurlat, Roland
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 285 - 285
  • [45] Bone matrix quality in paired iliac bone biopsies from postmenopausal women treated for 12 months with strontium ranelate or alendronate
    Falgayrac, Guillaume
    Farlay, Delphine
    Poncon, Camille
    Behal, Helene
    Gardegaront, Marc
    Ammann, Patrick
    Boivin, Georges
    Cortet, Bernard
    BONE, 2021, 153
  • [46] Uncoupling bone turnover with strontium ranelate, a promising agent for the treatment of postmenopausal osteoporosis
    Christiansen, C
    Tankó, LB
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S98 - S98
  • [47] Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis.
    Meunier, PJ
    Roux, C
    Ortolani, S
    Badurski, J
    Kaufman, JM
    Spector, T
    Diez-Perez, A
    Seeman, E
    Lemmel, E
    Balogh, A
    Pors-Nielsen, S
    Phenekos, C
    Rizzoli, R
    Slosman, D
    Tupinon-Mathieu, I
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 (06) : 521 - 522
  • [48] Strontium ranelate reduces the risk of non vertebral fractures in women with postmenopausal osteoporosis
    Reginster, JY
    Lorenc, RS
    Spector, TD
    Benhamou, C
    Isaia, G
    Brixen, K
    Stucki, G
    Prins, J
    Walravens, M
    Cannata, JB
    De Chatel, R
    Meunier, PJ
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S51 - S52
  • [49] BENEFICIAL EFFECTS OF STRONTIUM RANELATE COMPARED TO ALENDRONATE ON TRABECULAR BONE SCORE IN POST MENOPAUSAL OSTEOPOROTIC WOMEN: A 2-YEAR STUDY
    Hans, Didier
    Krieg, Marc-Antoine
    Lamy, Olivier
    Felsenberg, Dieter
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S266 - S267
  • [50] STRONTIUM RANELATE MAY IMPROVE MILD FORMS OF OSTEOARTHRITIS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Catalin, Cirstoiu F.
    Dan, Popescu
    Razvan, Ene
    Monica, Cirstoiu
    Anca, Popescu
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S273 - S274
12345